Serial #99131435
LIVE

Serial Number

99131435

Owner

Axsome Therapeutics, Inc.

Attorney

Brent Johnson

Filing Date

Apr 10, 2025

Add to watchlist:

No watchlists yet
View on USPTO

Serial #99131435 Trademark

Serial Number: 99131435

Serial #99131435 is a trademark filed by Axsome Therapeutics, Inc. on April 10, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 38 (Telecommunications), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Axsome Therapeutics, Inc. (67 trademarks)

New York, NY 10007

Entity Type: 03

Trademark Details

Filing Date

April 10, 2025

Registration Date

Not Registered

Published for Opposition

November 4, 2025

Goods & Services

Promoting public awareness of migraines; providing business management of pharmacy benefit programs that feature a medical benefit co-pay card

Downloadable cloud-based software for the purpose of tracking, managing and storing information related to medications and medication compliance, patient health, wellness and symptoms, and patient diseases and disorders; Downloadable software in the nature of a mobile application for the purpose of tracking, managing and storing information related to medications and medication compliance, patient health, wellness and symptoms, and patient diseases and disorders

financial management of pharmacy benefit programs for others that feature a medical benefit co-pay card; Financial administration of patient financial assistance eligibility programs featuring a pharmacy benefit co-pay card; providing financial assistance in the form of prepaid co-pay cards to patients for use in receiving medical benefits

Medicated and pharmaceutical preparations for use in connection with humans, namely, antibiotics, antifungals preparations, antivirals, and for treatment of cardiovascular, dermatological, respiratory, central nervous system, gastro-intestinal diseases, autoimmune, metabolic, endocrine, musculo-skeletal, genitourinary, tissue and organ, ocular, ophthalmological, immune system, pain, kidney, urological, and bone diseases and disorders and for the treatment of fibromyalgia, smoking cessation, narcolepsy, excessive daytime sleepiness, alzheimer's disease agitation, migraine, depression, diabetes, hypertension, skin disorders, allergies, asthma, obesity, and hair loss

Printed educational materials in the field of migraines

Consulting services in the field of health relating to pharmaceuticals; Providing health information relating to pharmaceuticals; Providing health information relating to pharmaceuticals via a website; Providing medical information relating to pharmaceuticals via a website; Providing news and information in the field of medicine relating to pharmaceuticals; Providing on-line information, news and commentary in the field of health and wellness relating to pharmaceuticals; Providing health information; providing health information via a website; providing medical information via a website; providing medical information in the field of depression and treatments for depression; providing mental health information via a website; providing mental health and wellness information; providing news and information in the field of medicine; providing news and information in the field of mental health about depression and treatments for depression; providing on-line information, news and commentary in the field of health and wellness relating to depression and treatments for depression; Providing healthcare information in the field of migraines; Providing healthcare information in the field of migraines via a website

Providing an on-line forum for patients and doctors to communicate and discuss depression and treatments for depression

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 11, 2026 EXRA
SOU EXTENSION 1 GRANTED
Jun 10, 2026 EX1G
SOU EXTENSION 1 FILED
Jun 10, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 10, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 30, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 4, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 4, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 29, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 1, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 30, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 30, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 30, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 30, 2025 CNEA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 18, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 18, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 18, 2025 REAP
EXAMINER'S AMENDMENT ENTERED
Sep 16, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 16, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 16, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 16, 2025 CNEA
ASSIGNED TO EXAMINER
Sep 8, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 21, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 21, 2025 NWOS
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 2, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 2, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 2, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 2, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 2, 2025 COAR
APPLICATION FILING RECEIPT MAILED
Apr 10, 2025 MAFR
NEW APPLICATION ENTERED
Apr 10, 2025 NWAP